Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

PROgnostic Model for Advanced Cancer (PRO-MAC).

Hum A, Wong YKY, Yee CM, Lee CS, Wu HY, Koh MYH.

BMJ Support Palliat Care. 2019 Apr 4. pii: bmjspcare-2018-001702. doi: 10.1136/bmjspcare-2018-001702. [Epub ahead of print]

PMID:
30948445
2.

Hypoxia-Associated Factor (HAF) Mediates Neurofibromin Ubiquitination and Degradation Leading to Ras-ERK Pathway Activation in Hypoxia.

Green YS, Sargis T, Reichert EC, Rudasi E, Fuja D, Jonasch E, Koh MY.

Mol Cancer Res. 2019 May;17(5):1220-1232. doi: 10.1158/1541-7786.MCR-18-1080. Epub 2019 Jan 31.

PMID:
30705246
3.

ED-PALS: A Comprehensive Palliative Care Service for Oncology Patients in the Emergency Department.

Koh MYH, Lee JF, Montalban S, Foo CL, Hum AYM.

Am J Hosp Palliat Care. 2019 Jul;36(7):571-576. doi: 10.1177/1049909119825847. Epub 2019 Jan 23.

PMID:
30674197
4.

Chitosan-catechol: a writable bioink under serum culture media.

Lee D, Park JP, Koh MY, Kim P, Lee J, Shin M, Lee H.

Biomater Sci. 2018 May 1;6(5):1040-1047. doi: 10.1039/c8bm00174j.

PMID:
29666857
5.

EGFR-Induced and PKCε Monoubiquitylation-Dependent NF-κB Activation Upregulates PKM2 Expression and Promotes Tumorigenesis.

Yang W, Xia Y, Cao Y, Zheng Y, Bu W, Zhang L, You MJ, Koh MY, Cote G, Aldape K, Li Y, Verma IM, Chiao PJ, Lu Z.

Mol Cell. 2018 Jan 18;69(2):347. doi: 10.1016/j.molcel.2017.12.034. No abstract available.

6.

Definition of a Novel Feed-Forward Mechanism for Glycolysis-HIF1α Signaling in Hypoxic Tumors Highlights Aldolase A as a Therapeutic Target.

Grandjean G, de Jong PR, James B, Koh MY, Lemos R, Kingston J, Aleshin A, Bankston LA, Miller CP, Cho EJ, Edupuganti R, Devkota A, Stancu G, Liddington RC, Dalby K, Powis G.

Cancer Res. 2016 Jul 15;76(14):4259-4269. doi: 10.1158/0008-5472.CAN-16-0401. Epub 2016 Jun 3.

7.

A new HIF-1α/RANTES-driven pathway to hepatocellular carcinoma mediated by germline haploinsufficiency of SART1/HAF in mice.

Koh MY, Gagea M, Sargis T, Lemos R Jr, Grandjean G, Charbono A, Bekiaris V, Sedy J, Kiriakova G, Liu X, Roberts LR, Ware C, Powis G.

Hepatology. 2016 May;63(5):1576-91. doi: 10.1002/hep.28468. Epub 2016 Mar 7.

8.

Burnout, psychological morbidity and use of coping mechanisms among palliative care practitioners: A multi-centre cross-sectional study.

Koh MY, Chong PH, Neo PS, Ong YJ, Yong WC, Ong WY, Shen ML, Hum AY.

Palliat Med. 2015 Jul;29(7):633-42. doi: 10.1177/0269216315575850. Epub 2015 Mar 31.

PMID:
25829444
9.

Hypoxia-induced SUMOylation of E3 ligase HAF determines specific activation of HIF2 in clear-cell renal cell carcinoma.

Koh MY, Nguyen V, Lemos R Jr, Darnay BG, Kiriakova G, Abdelmelek M, Ho TH, Karam J, Monzon FA, Jonasch E, Powis G.

Cancer Res. 2015 Jan 15;75(2):316-29. doi: 10.1158/0008-5472.CAN-13-2190. Epub 2014 Nov 24.

10.

EGFR-induced and PKCε monoubiquitylation-dependent NF-κB activation upregulates PKM2 expression and promotes tumorigenesis.

Yang W, Xia Y, Cao Y, Zheng Y, Bu W, Zhang L, You MJ, Koh MY, Cote G, Aldape K, Li Y, Verma IM, Chiao PJ, Lu Z.

Mol Cell. 2012 Dec 14;48(5):771-84. doi: 10.1016/j.molcel.2012.09.028. Epub 2012 Nov 1. Erratum in: Mol Cell. 2018 Jan 18;69(2):347.

11.

Passing the baton: the HIF switch.

Koh MY, Powis G.

Trends Biochem Sci. 2012 Sep;37(9):364-72. doi: 10.1016/j.tibs.2012.06.004. Epub 2012 Jul 18. Review.

12.
13.

The hypoxia-associated factor switches cells from HIF-1α- to HIF-2α-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion.

Koh MY, Lemos R Jr, Liu X, Powis G.

Cancer Res. 2011 Jun 1;71(11):4015-27. doi: 10.1158/0008-5472.CAN-10-4142. Epub 2011 Apr 21.

14.

Modification of polyglutamic acid with silanol groups and calcium salts to induce calcification in a simulated body fluid.

Koh MY, Ohtsuki C, Miyazaki T.

J Biomater Appl. 2011 Feb;25(6):581-94. doi: 10.1177/0885328209357111. Epub 2010 Mar 5.

PMID:
20207777
15.

HIF-1alpha and cancer therapy.

Koh MY, Spivak-Kroizman TR, Powis G.

Recent Results Cancer Res. 2010;180:15-34. doi: 10.1007/978-3-540-78281-0_3. Review.

PMID:
20033376
16.

Inhibiting the hypoxia response for cancer therapy: the new kid on the block.

Koh MY, Spivak-Kroizman TR, Powis G.

Clin Cancer Res. 2009 Oct 1;15(19):5945-6. doi: 10.1158/1078-0432.CCR-09-1650. Epub 2009 Sep 29.

17.

In vitro apatite formation on organic-inorganic hybrids in the CaO-SiO(2)-PO (5/2)-poly(tetramethylene oxide) system.

Koh MY, Kamitakahara M, Kim IY, Kikuta K, Ohtsuki C.

J Mater Sci Mater Med. 2010 Feb;21(2):385-92. doi: 10.1007/s10856-009-3868-0. Epub 2009 Sep 16.

PMID:
19756965
18.

HAF : the new player in oxygen-independent HIF-1alpha degradation.

Koh MY, Powis G.

Cell Cycle. 2009 May 1;8(9):1359-66. Review.

19.
20.

Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.

Baker AF, Koh MY, Williams RR, James B, Wang H, Tate WR, Gallegos A, Von Hoff DD, Han H, Powis G.

Pancreas. 2008 Mar;36(2):178-86. doi: 10.1097/MPA.0b013e31815929fe.

PMID:
18376310
21.

Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1alpha.

Koh MY, Spivak-Kroizman T, Venturini S, Welsh S, Williams RR, Kirkpatrick DL, Powis G.

Mol Cancer Ther. 2008 Jan;7(1):90-100. doi: 10.1158/1535-7163.MCT-07-0463.

22.

The hypoxic inducible stress response as a target for cancer drug discovery.

Welsh SJ, Koh MY, Powis G.

Semin Oncol. 2006 Aug;33(4):486-97. Review.

PMID:
16890803
23.

Expression of kinase-defective mutants of c-Src in human metastatic colon cancer cells decreases Bcl-xL and increases oxaliplatin- and Fas-induced apoptosis.

Griffiths GJ, Koh MY, Brunton VG, Cawthorne C, Reeves NA, Greaves M, Tilby MJ, Pearson DG, Ottley CJ, Workman P, Frame MC, Dive C.

J Biol Chem. 2004 Oct 29;279(44):46113-21. Epub 2004 Aug 23.

Supplemental Content

Support Center